Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
3,588,107
-
Shares change
-
-779,786
-
Total reported value, excl. options
-
$154,367,900
-
Value change
-
-$32,885,765
-
Number of buys
-
19
-
Number of sells
-
38
-
Price
-
$43.01
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2018
As of 30 Jun 2018 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,588,107 shares of stock of the company.
Largest 10 holders included DEUTSCHE BANK AG\, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, BNP PARIBAS ARBITRAGE, SA, JGP Global Gestao de Recursos Ltda., Baird Financial Group, Inc., Wharton Business Group, LLC, and UBS Group AG.
This table shows 82 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.